Log In
BCIQ
Print this Print this
 

AIC284

  Manage Alerts
Collapse Summary General Information
Company AiCuris GmbH & Co. KG
DescriptionCytokine analog (Interleukin-2 mutein)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today